Health Blueprint

Back to Longevity News

News summary

Translational trends and specific nutritional interventions for aromatase inhibitor induced bone loss based on a 25 year multi database bibliometric and thematic evolution analysis from 2000 to 2025

Source: Frontiers - Health • Published: 26 Oct 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

A 25-year bibliometric review mapped nutritional interventions for AIBL.

Translational trends and specific nutritional interventions for aromatase inhibitor induced bone loss based on a 25 year multi database bibliometric and thematic evolution analysis from 2000 to 2025
Key Takeaways
  • Aromatase inhibitors are linked to accelerated bone loss.
  • Calcium and vitamin D are used to support bone mineralization.
  • Dietary patterns and gut metabolites were found to affect bone resorption.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.